FDA authorizes Pfizer for ages 12 through 15

Staff Report

Adolescents ages 12 through 15 could soon receive the Pfizer-BioNTech COVID-19 vaccine.

On Monday, the U.S. Food and Drug Administration (FDA) authorized the vaccine for emergency use to include a younger age range. Teens at least 16 years old and all adults were already eligible.

“[The decision] is a significant step in the fight against the COVID-19 pandemic,” said Janet Woodcock, FDA Commissioner. “Today’s action allows for a younger population to be protected from COVID-19, bringing us closer to returning to a sense of normalcy and to ending the pandemic.”

Woodcock added that the FDA critically reviewed available data before issuing COVID-19 vaccine emergency use authorizations (EUA).

The Centers for Disease Control and Prevention’s (CDC) vaccine advisory committee will meet Wednesday, May 12, to review whether to distribute the doses to adolescents.

For more information, please visit  https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-pfizer-biontech-covid-19-vaccine-emergency-use

Comment on this Article

About Author

Megan Wehring graduated from Texas State University in May 2020 with a bachelor's degree in journalism and mass communication. Wehring has reported for the Hays Free Press/News-Dispatch for a year, covering all things local. This includes city council meetings, town events, education and human interest stories. Previously, Wehring worked at KTSW FM-89.9 (Texas State University's official radio station) for two consecutive years. She was a news reporter, assistant news director and monthly segment producer during her time at KTSW. Wehring is passionate about the local reporter aspect. With a heart for storytelling, she believes that journalists are equipped to share the stories that are most important to the community.

Comments are closed.